Since hepatic lipid accumulation plays an important role in developing whole-body insulin resistance [32], the GCN2 inhibition-mediated alleviation of hepatic steatosis may also be responsible for the increased insulin sensitivity in T2D mice. The gene discussed is INS; the disease is Hepatic steatosis.